Source:http://linkedlifedata.com/resource/pubmed/id/18329538
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-3-10
|
pubmed:abstractText |
Skin sclerosis is a clinical hallmark of systemic sclerosis (SSc) and provides a means to classify and evaluate patients. In the diffuse cutaneous subset, skin involvement is often extensive and warrants direct therapy. Currently, broad spectrum immunosuppressive strategies are used, but more targeted specific approaches are now emerging. This article reviews the evidence for efficacy of current treatment approaches and future developments for managing skin disease in early diffuse cutaneous SSc.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0889-857X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
161-79; viii
|
pubmed:meshHeading |
pubmed-meshheading:18329538-Antilymphocyte Serum,
pubmed-meshheading:18329538-Fibrosis,
pubmed-meshheading:18329538-Humans,
pubmed-meshheading:18329538-Immunosuppressive Agents,
pubmed-meshheading:18329538-Immunotherapy,
pubmed-meshheading:18329538-Photopheresis,
pubmed-meshheading:18329538-Scleroderma, Diffuse,
pubmed-meshheading:18329538-Severity of Illness Index
|
pubmed:year |
2008
|
pubmed:articleTitle |
Current approaches to the management of early active diffuse scleroderma skin disease.
|
pubmed:affiliation |
Centre for Rheumatology, Royal Free Hospital, Pond Street, London NW3 2QG, UK.
|
pubmed:publicationType |
Journal Article,
Review
|